Buy or sell Caribou Biosciences stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Caribou Biosciences Stock
Biotechnology company specializing in genome engineering
About Caribou Biosciences Stock
Investors
Anterra Capital
F-Prime Capital Partners
PharmEasy, Devoted Health, Benchling, SonderMind, Prime Medicine, Snapdocs, Flywire, Quartet, Caribou Biosciences, Unison Home Ownership Investors
Genoa Ventures
Heritage Group
Actifio, Reputation.com, Factual, ClearDATA, Caribou Biosciences
Maverick Ventures
Devoted Health, Cityblock Health, Collective Health, One Medical, LTK, Snapdocs, Heap, Bungalow, BioCatch, Caribou Biosciences
Mission Bay Capital
Novartis
Pontifax AgTech
Funding History
October 2014 | $2.9M |
---|---|
March 2015 | $11.5M |
May 2016 | $30.0M |
May 2016 | $30.1M |
Management
Co-Founder
Jennifer A. Doudna
Co-Founder
James Berger
Chief Scientific Officer
Andy May
Press
businesswire - Sep, 26 2019
businesswire - Feb, 12 2019
TechCrunch - Sep, 4 2018
Business Wire (press release) - May, 3 2018
OZY - Mar, 16 2018
Business Wire (press release) - Jul, 6 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase